Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Clinical and Molecular Features of 5 European Multigenerational Families With Moyamoya Angiopathy.

Authors:
Lou Grangeon Stéphanie Guey Jan Claudius Schwitalla Françoise Bergametti Minh Arnould Michaelle Corpechot Jessica Hadjadj Florence Riant Chaker Aloui Severine Drunat Dominique Vidaud Elisabeth Tournier-Lasserve Markus Kraemer

Stroke 2019 04;50(4):789-796

Department of Neurology, Alfried Krupp Hospital Essen, Germany (J.C.S., M.K.).

Background and Purpose Moyamoya angiopathy (MMA) is a rare cerebral vasculopathy outside of Asia. In Japanese patients, a vast majority of patients carry the founder p.R4810K variant in the RNF213 gene, and familial cases are around 10%. In European patients, data about familial occurrence are limited. The aim of this study was to characterize the clinical and molecular features of several European families with a parent-to-child transmission of MMA. Methods Out of 126 MMA probands referred, we identified 113 sporadic probands and 13 familial probands. Segregation analysis showed a vertical parent-to-child pattern of inheritance in the families of 5 of these probands. All 5 families were of German or Dutch ancestry. We investigated the clinical features of affected members and used whole-exome sequencing to screen RNF213 and 13 genes involved in Mendelian MMA and to identify genes recurrently mutated in these families. Results Twelve affected MMA patients were identified, including 9 females and 3 males. Age at clinical onset ranged from 11 to 65 years. In 3 of 5 families, associated livedo racemosa was found. We did not detect any deleterious variants in the 13 known MMA genes. RNF213 rare missense variants predicted to be pathogenic were detected in all affected members of 2 of these families, as well as 2 candidate variants of the PALD1 gene. Conclusions Nonsyndromic MMA was identified in 5 European families, including 2 to 3 clinically affected cases segregating with a parent-to-child pattern of inheritance in each family. Molecular screening detected rare deleterious variants within RNF213 and PALD1 in all affected members of 2 of these 5 families, as well as in some clinically unaffected members. Altogether these data raise the difficult and, to date unanswered, question of the medical indication of presymptomatic screening.

Download full-text PDF

 Source
http://dx.doi.org/10.1161/STROKEAHA.118.023972DOI Listing
April 2019

Publication Analysis

Top Keywords

families
9
families well
8
european families
8
pattern inheritance
8
moyamoya angiopathy
8
features european
8
clinical molecular
8
members families
8
molecular features
8
deleterious variants
8
parent-to-child pattern
8
mma
7
whole-exome sequencing
4
segregating parent-to-child
4
members
4
clinical features
4
investigated clinical
4
sequencing screen
4
features members
4
clinical
4

Similar Publications

Novel thienopyrimidine analogues as potential metabotropic glutamate receptors inhibitors and anticancer activity: Synthesis, In-vitro, In-silico, and SAR approaches.

Authors:
Mohammed A Khedr Khadiga M Abu-Zied Wafaa A Zaghary Ahmed S Aly Dina N Shouman Hesham Haffez

Bioorg Chem 2021 Feb 16;109:104729. Epub 2021 Feb 16.

Biochemistry and Molecular Biology Department, Faculty of Pharmacy, Helwan University, P.O. Box 11795, Cairo, Egypt; Center of Scientific Excellence "Helwan Structural Biology Research, (HSBR)", Helwan University, Cairo 11795, Egypt.

There is a continuous need in drug development approach for synthetic anticancer analogues with new therapeutic targets to diminish chemotherapeutic resistance of cancer cells. This study presents new group of synthetic thienopyrimidine analogues (1-9) aims as mGluR-1 inhibitors with anticancer activity. In-vitro antiproliferative assessment was carried out using viability assay against cancer cell lines (MCF-7, A-549 and PC-3) compared to WI-38 normal cell line. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy.

Authors:
Nicola Giesen Rosanne Sprute Maria Rüthrich Yascha Khodamoradi Sibylle C Mellinghoff Gernot Beutel Catherina Lueck Michael Koldehoff Marcus Hentrich Michael Sandherr Michael von Bergwelt-Baildon Hans-Heinrich Wolf Hans H Hirsch Bernhard Wörmann Oliver A Cornely Philipp Köhler Enrico Schalk Marie von Lilienfeld-Toal

Eur J Cancer 2021 Feb 10;147:154-160. Epub 2021 Feb 10.

Department of Haematology and Medical Oncology, Clinic for Internal Medicine II, University Hospital Jena, Jena, Germany; Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany.

The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious coronavirus disease (COVID-19) has posed a unique challenge to medical staff, patients and their families. Patients with cancer, particularly those with haematologic malignancies, have been identified to be at high risk to develop severe COVID-19. Since publication of our previous guideline on evidence-based management of COVID-19 in patients with cancer, research efforts have continued and new relevant data has come to light, maybe most importantly in the field of vaccination studies. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Dissulfurispira thermophila gen. nov., sp. nov., a thermophilic chemolithoautotroph growing by sulfur disproportionation, and proposal of novel taxa in the phylum Nitrospirota to reclassify the genus Thermodesulfovibrio.

Authors:
Kazuhiro Umezawa Hisaya Kojima Yukako Kato Manabu Fukui

Syst Appl Microbiol 2021 Feb 11;44(2):126184. Epub 2021 Feb 11.

The Institute of Low Temperature Science, Hokkaido University. Kita-19, Nishi-8, Kita-ku, Sapporo 060-0819, Japan.

Recently, presence of sulfur-disproportionating bacterial species belonging to the phylum Nitrospirota was indicated by an enrichment culture-based study. In the present study, a strain representing that species was isolated and characterized. The strain, strain T55J, was isolated from a microbial mat of a hot spring. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

A modified screening strategy for Lynch syndrome among MLH1-deficient CRCs: Analysis from consecutive Chinese patients in a single center.

Authors:
Wenmiao Wang Jianming Ying Susheng Shi Qiurong Ye Shuangmei Zou Lin Dong Ning Lyu

Transl Oncol 2021 Mar 3;14(5):101049. Epub 2021 Mar 3.

Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China. Electronic address:

Background: The low prevalence of the BRAF V600E mutation in colorectal cancers (CRCs) in Chinese populations has stimulated concern about the efficacy of BRAF mutation analysis for Lynch syndrome (LS) screening.

Methods: In total, 169 of 4104 consecutive CRC patients with absent MLH1 staining were analyzed to compare the utility of the BRAF V600E mutation testing with MLH1 promoter methylation analysis in the Chinese population. Germline genetic testing was performed in patients with wild-type BRAF/methylated MLH1. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Comparative metabolic study of Citrus sinensis leaves cultivars based on GC-MS and their cytotoxic activity.

Authors:
Ahmed K Kammoun Ahmed E Altyar Haidy A Gad

J Pharm Biomed Anal 2021 Feb 26;198:113991. Epub 2021 Feb 26.

Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. Electronic address:

Citrus sinensis L. Osbeck, (family Rutaceae), known as sweet orange, is a fruit-bearing shrub that widely cultivated all over the world due to its nutritive value, nutraceutical attributes and economic importance. In the present study, a comparative metabolic profile study of the essential oils of the leaves of nine cultivars of Citrus sinensis cultivated in Egypt was carried out based on GC-MS analysis coupled to chemometrics. Read More

View Article and Full-Text PDF
February 2021
Similar Publications